THE BASIC PRINCIPLES OF ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

These side effects ended up notably milder in comparison to an inhibitor of both of those bromodomains. An in depth molecular Evaluation also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor88 These preclinical studies give paradigms for long run clinical trials in AML, a